Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Upadacitinib
Upadacitinib
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
RINVOQ 15 mg prolonged-release tablets
Updated
SPC
PIL
No
A
Upadacitinib
AbbVie Limited
RINVOQ 30 mg prolonged-release tablets
Updated
SPC
PIL
No
A
Upadacitinib
AbbVie Limited
RINVOQ 45 mg prolonged-release tablets
Updated
SPC
PIL
No
A
Upadacitinib
AbbVie Limited
Cookies
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Product subject to medical prescription which may not be renewed (A)
